3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Osteosarcoma
1
Melanoma
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Ifosfamide
5
Doxorubicin
4
Specimen Handling
3
Methotrexate
3
Etoposide
3
Cisplatin
3
Sorafenib
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
sodium thiosulfate
1
sargramostim
1
pepinemab
1
peginterferon alfa-2b
1
mifamurtide
1
merphos
1
lorukafusp alfa
1
irinotecan sucrosofate
1
imetelstat
1
etoposide phosphate
1
Zoledronic Acid
1
X-Rays
1
Thrombopoietin
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Surgical Procedures, Operative
1
Reverse Transcriptase Polymerase Chain Reaction
1
Restraint, Physical
1
Razoxane
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Osteosarcoma
×
peginterferon alfa-2b
×
Clear all
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts